微信扫码
暂无在线客服
用户中心 意见反馈
返回顶部
Home >News > Company news

New Generation High Performance Magnetic Microspheres Launched

分享到:
点击次数:19 更新时间:2026年08月27日09:53:32 打印此页 关闭

New Generation High Performance Magnetic Microspheres Launched

Empowering CLIA and Enabling Efficient Bioseparation Workflows

In the fields of chemiluminescence immuno‑diagnosis and biosample separation‑purification, magnetic microspheres serve as core solid‑phase carriers. Their particle‑size uniformity, magnetic‑response speed and coupling efficiency directly determine assay sensitivity, reproducibility and manufacturing stability of diagnostic kits. To meet the industry’s urgent demand for high‑performance domestic magnetic‑bead raw materials, Meafound Biotechnology has launched its series of monodisperse polymer‑based magnetic microspheres: Carboxyl Magnetic Microspheres (Mag‑COOH) and Streptavidin Magnetic Microspheres (Mag‑SA). They deliver reliable domestic solutions for in‑vitro diagnostic reagent development and biomolecule capture‑purification.

Two Core Products Covering Mainstream Application Scenarios

Carboxyl Magnetic Microspheres (Mag‑COOH)

The bead surface is densely functionalized with abundant carboxyl (‑COOH) groups. Upon standard EDC/NHS activation, stable covalent conjugation can be achieved with amino‑containing biomolecules including antibodies, antigens and nucleic acids. It is the preferred solid‑phase material for antibody‑antigen immobilization and chemiluminescence immunoassay kit development. No complicated pre‑treatment is required. Suitable for the full workflow from reagent R&D to large‑scale manufacturing to support various immunoassay projects.

Streptavidin Magnetic Microspheres (Mag‑SA)

Manufactured by covalently coupling streptavidin onto carboxyl magnetic microspheres, this product is specially engineered for chemiluminescence detection platforms and biotin‑streptavidin signal‑amplification systems. Leveraging the high‑specificity binding between biotin and streptavidin, the beads efficiently capture diverse biotin‑labelled target molecules, greatly boosting assay signals and minimizing non‑specific background. Well‑suited for high‑throughput tests on fully‑automated chemiluminescence instruments.

Four Key Advantages Addressing Critical Reagent‑development Pain Points

  1. Highly Uniform Particle Size for Reliable Batch‑to‑batch Consistency

    Fabricated as monodisperse microspheres via high‑molecular‑weight polymer matrices with ultra‑narrow particle‑size distribution. It reduces batch‑to‑batch variations and guarantees consistent test results, complying with strict quality‑control requirements for large‑scale IVD production.

  2. Fast Magnetic Response with Excellent Re‑dispersibility

    Achieve rapid magnetic enrichment under magnetic fields. After magnetic separation, beads can be readily re‑suspended without aggregation or sedimentation. It simplifies manual handling and adapts to high‑speed operation of automated instruments.

  3. Versatile Surface Modifications for Diverse Conjugation Requirements

    Two mainstream surface‑functionalized options (carboxyl and streptavidin) support two major technical routes: direct covalent coating and indirect biotin‑mediated capture, matching different reagent‑development strategies.

  4. Broad Platform Compatibility for Mainstream CLIA Instruments

    Fully validated to be compatible with most commercially‑available chemiluminescence immunoassay platforms. Diagnostic manufacturers can implement raw‑material replacement and methodological validation efficiently to shorten time‑to‑market.

Main Application Areas

  • Development of Chemiluminescence Immunoassay (CLIA) kits 

  • Capture, separation and purification of antibodies and antigens 

  • Biotin‑streptavidin signal‑amplification detection systems 

  • Raw materials for automated magnetic‑separation detection workstations

Supplied at 10 mg/mL (5%) with multiple packaging sizes: 1 mL, 10 mL and 100 mL, covering lab‑scale R&D trials as well as large‑volume industrial procurement.

About Meafound Biotechnology

Meafound Biotechnology focuses on R&D and manufacturing of magnetic‑microsphere biological carriers. Its production site is located in Sanming, Fujian Province. The company is committed to delivering cost‑effective domestic magnetic‑bead materials and supplying dependable upstream consumables for in‑vitro diagnostics and life‑science research.

Contact Information 

Tel: +86‑18659885473 

Fax: +86‑0598‑8276386 

Website: https://www.meafound.com

E‑mail: lisa‑lu@meafound.com

Whether for small‑batch sampling in reagent development or mass industrial production of diagnostic kits, please feel free to contact us for samples and technical support. Let's advance the localization of high‑performance magnetic microspheres together.

下一条:Who needs to be tested for Glycated hemoglobin?